摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 135865-67-7

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
135865-67-7
化学式
C24H56Cl2N4O4P4Pd
mdl
——
分子量
765.954
InChiKey
SWMZQSKSSWRTKA-DCPUHOFNSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10.83
  • 重原子数:
    39.0
  • 可旋转键数:
    12.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    49.88
  • 氢给体数:
    0.0
  • 氢受体数:
    8.0

反应信息

  • 作为产物:
    描述:
    palladium(II) chloride benzonitrile complex 、 tris-((di-i-propylamino)phosphoxane)正己烷 为溶剂, 以40%的产率得到
    参考文献:
    名称:
    Coordination complexes derived from tri-, tetra-, and pentaphosphoxane rings
    摘要:
    Thermal reactions of hexacarbonylchromium and -tungsten with bis(diisopropylamino)phosphine oxide yielded the tetraphosphoxane complexes cis-M(CO)4[(i)Pr2NPO]4 as the major products. Spectral data and X-ray structural determination of the molybdenum analogue confirmed 1,5-coordination of statistical mixtures of the chair-boat (C(S)) and chair-chair (C2-upsilon) conformations of the P4O4 ring. Crystal data: monoclinic, A2/a; a = 18.992 (1), b = 11.306 (5), c = 19.368 (1) angstrom; beta = 98.63 (1)-degrees; V = 4111.6 (4) angstrom 3; Z = 4; final R(F) = 0.062, R(wF) = 0.057 for 2219 significant reflections and varying 204 parameters. Minor coproducts from the chromium reaction included Cr2(CO)8[(i)Pr2NPO]4, with a tetradentate P4O4 ring chelating both metals, as well as Cr2(CO)7[(i)Pr2NPO]5. The latter structure features a novel pentaphosphoxane P5O5 ring coordinated to one Cr(CO)3 and one Cr(CO)4 to form a bimetallic cage. Crystal data: monoclinic, P2(1)/c; a = 12.6554 (8), b = 17.639 (1), c = 23.670 (1) angstrom; beta = 101.82 (1)-degrees; V = 5171.7 (5) angstrom 3; Z = 4; final R(F) = 0.088, R(wF) = 0.081 for 4337 significant reflections and varying 491 parameters. Under milder reaction conditions with molybdenum hexacarbonyl, a triphosphoxane complex Mo(CO)5[(i)Pr2NPO]3 can be isolated. Crystal data: orthorhombic, Pbc2(1); a = 11.570 (2), b = 18.729 (5), c = 32.056 (3) angstrom; V = 6946.36 angstrom 3; Z = 8; final R(F) = 0.047, R(wF) = 0.048 for 3469 significant reflections and varying 685 parameters. This was converted readily by heating to the known Mo2(CO)8[(i)Pr2NPO]4 cage complex. Reactions of the parent [(i)Pr2NPO]3 triphosphoxane ring with Mo(CO)4(norbornadiene) afforded a 1:1 complex cis-Mo(CO)4-[(i)Pr2NPO]3 which also transformed into the same adamantanoid cage complex upon warming. With bis(benzonitrile)palladium dichloride, triphosphoxane gave a product characterized by spectral data and X-ray crystallography to be cis-PdCl2[(i)Pr2NPO]4 with a 1,5-coordinated tetraphosphoxane ring exclusively in the chair-chair (C2-upsilon) conformation. Crystal data: monoclinic C2/c; a = 19.980 (5), b = 11.0945 (10), c = 17.934 (9) angstrom; beta = 112.04 (3)-degrees; V = 3684.8 angstrom 3; Z = 4; final R(w) = 0.051 and R(wF) = 0.060 for 252 variables using 3246 significant reflections. A similar reaction with NiBr2.DME (DME = dimethoxyethane) yielded instead a 1,3-coordinated P4O4 complex NiBr2[(i)Pr2NPO]4. The parent [(i)Pr2NPO]4 ligand, stable below -20-degrees-C, can be liberated from this Ni complex by pyridine substitution. It reverts to the triphosphoxane compound upon warming to ambient temperature.
    DOI:
    10.1021/om00055a011
点击查看最新优质反应信息

同类化合物

尿苷5'-二磷酸酯溴乙酰醇 N,N-二乙基-4-甲基-1,3,2-二氧杂磷杂环戊烷-2-胺 4,4,5,5-四甲基-1,3,2-二氧磷杂环戊烷-2-醇 2-氯-4-甲基-1,3,2-二氧杂磷杂环戊烷 2-氯-4,4,5,5-四甲基-1,3,2-二氧磷杂环戊烷 2-氯-1,3,2-二氧磷杂环戊烷 (3,5-二甲基苯基)[羟基(吡啶-4-基甲基)-lambda~5~-氮烷基]甲酮 2-Dipropylamino-<1,3,2 λ3>dioxaphospholan 2-ethoxy-[1,3,2]oxazaphospholidine Ethylen-2.2.2-trifluorethylphosphit-ozonid 2-dimethylamino-(3ar,9ac,3'ar',9'ac')-hexadecahydro-2λ5-[2,2']spirobi(cycloocta[1,3,2]dioxaphosphole) 2,7-dimethyl-1,4,6,9-tetraoxa-5(λ5)-phosphaspiro<4.4>nonane Aethylenselenit 4,5-bis-trifluoromethyl-2λ5-spiro[[1,3,2]dioxaphosphole-2,1'-(2,8,9-trioxa-1-phospha-adamantane)] 5,5-Difluoro-1,4,6,9-tetraoxa-5λ6-tellura-spiro[4.4]nonane N-methyl-1-(1,4,6,9-tetraoxa-5λ5-phosphaspiro[4.4]nonan-5-yl)-N-(1,4,6,9-tetraoxa-5λ5-phosphaspiro[4.4]nonan-5-ylmethyl)methanamine 2-methyl-5-(2,2,2-trichloroethoxy)-1,4,6,9-tetraoxa-5λ5-phosphaspiro[4.4]nonan-3-one Butan-2,3-diylselenit (4r,5t-dimethyl-[1,3,2]dioxaphospholan-2-yl)-dimethyl-amine 3,3-dibromo-2-fluoro-4-propyl-1,2λ5-oxaphosphetane 2-Fluor-2,2-dibrom-4,4,5,5-tetrakis-(trifluormethyl)-(1,3,2λ5-dioxaphospholan [1,3,2]dioxaphospholan-2-yl-ethyl-amine 2-tert-butylamino-2,2-difluoro-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholane 3,3-dichloro-2-fluoro-4-propyl-1,2λ5-oxaphosphetane 1,1-Dibromo-3,5,8-tris-(1,1,2,2-tetrafluoro-ethyl)-2,6,7-trioxa-1λ5,4-diphospha-bicyclo[2.2.2]octane 2-Brom-4,4,5,5-tetrakis-(trifluormethyl)-(1,3,2λ5-dioxaphospholan dibutyl-(4-methyl-[1,3,2]dioxaphospholan-2-yl)-amine 2-(tert-butylimino)-1,3,2,4-oxaazaphosphaboretidine 1,1,3,3,5,5,7,7-Tetrakis--tetraphosphazatetraen 2-Chlor-2,2-dibrom-4,4,5,5-tetrakis-(trifluormethyl)-(1,3,2λ5-dioxaphospholan 2-Propoxy-[1,3,2]dioxaphospholan-4-one 2-Fluor-2,2-dichlor-4,4,5,5-tetrakis-(trifluormethyl)-(1,3,2λ5-dioxaphospholan 2-fluoro-3-methyl-[1,3,2]oxazaphospholidine 2,2,2,4-tetrachloro-3-isopropyl-4-triflyoromethyl-1,3,2-λ5-oxazaphosphetane 1,1-Dichloro-3,5,8-tris-(1,1,2,2-tetrafluoro-ethyl)-2,6,7-trioxa-1λ5,4-diphospha-bicyclo[2.2.2]octane 2-ethoxy-2-fluoro-2λ5-[1,3,2]dioxaphospholan-2-yl phosphoric acid-(2-ethyl-2-butyl-propanediyl ester)-(2-bromo-propyl ester) (4,4-dimethyl-1,3,2-dioxaphospholan-2-yl) 2,2,2-trifluoroacetate 2-Dimethylamino-4,4,5,5-tetrakis(trifluormethyl)-1,3,2λ3-dioxaphospholan 2,3,3-Trichloro-2,2-diethyl-4-trichloromethyl-2λ5-[1,2]oxaphosphetane (5-tert-butyl-[1,3,2]dioxaphosphinan-2-yl)-dimethyl-amine 2-cyclohexyl-[1,3,2]dioxaphospholane (4-tert-Butyl-[1,3,2]dioxaphospholan-2-yl)-diethyl-amine N-Methyl-N-[1-methyl-2-(4,4,5,5-tetramethyl-[1,3,2]dioxaphospholan-2-yloxy)-propyl]-acetamide 2,2-Dichlor-2-dimethylamino-4,4,5,5-tetrakis(trifluormethyl)-1,3,2λ5-dioxaphospholan methyl-2-trioxaphosphocanne-1,3,6,2 5-dimethylamino-2,4-diisopropylidene-1,3,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane